In Brief: Fischer Imaging
This article was originally published in The Gray Sheet
Fischer Imaging: Plans to begin clinical trials of its SenoScan full field digital mammography system within the next month at Thomas Jefferson University Hospital in Philadelphia. Fischer intends to expand the studies to a total of three U.S. sites over the summer, treating between 400 and 500 patients. A 510(k) submission is planned for later this year. The device employs a scanning x-ray beam technique to produce a 20 mil. pixel image in four to five seconds...
You may also be interested in...
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.